In conclusion, we have demonstrated that miR-381 suppressed Cx43 expression by directly targeting the 3′-UTR of CEBPA, a novel transcription factor of Cx43 in human breast cancer cells. This evidence concerns the gene CEBPA and breast carcinoma.